Triastek's T22 Gastric Retention Capsules Gain NMPA IND Clearance
CompanyDrug

Triastek’s T22 Gastric Retention Capsules Gain NMPA IND Clearance

Boehringer Ingelheim's Metalyse Approved in China for Acute Ischemic Stroke
CompanyDrug

Boehringer Ingelheim’s Metalyse Approved in China for Acute Ischemic Stroke

Well Lead Medical to Set Up Subsidiary and Manufacturing Base in Indonesia
Company

Well Lead Medical to Set Up Subsidiary and Manufacturing Base in Indonesia

Kelun-Biotech's Sacituzumab Tirumotecan Accepted for NMPA Review for HR+, HER2- Breast Cancer
CompanyDrug

Kelun-Biotech’s Sacituzumab Tirumotecan Accepted for NMPA Review for HR+, HER2- Breast Cancer

Shandong Buchang Pharmaceuticals Partners with FBC for MF59 Adjuvant R&D
CompanyDeals

Shandong Buchang Pharmaceuticals Partners with FBC for MF59 Adjuvant R&D

HHS Implements Trump's Order for Most-Favored-Nation Drug Pricing
Policy / Regulatory

HHS Implements Trump’s Order for Most-Favored-Nation Drug Pricing

Nuance Pharma's Ohtuvayre Meets Primary Endpoints in COPD Study
CompanyDrug

Nuance Pharma’s Ohtuvayre Meets Primary Endpoints in COPD Study

AccurEdit Therapeutics' ART001 Receives FDA RMAT Designation for ATTR
CompanyDrug

AccurEdit Therapeutics’ ART001 Receives FDA RMAT Designation for ATTR

AstraZeneca Completes Acquisition of EsoBiotec for Up to USD 1 Billion
CompanyDeals

AstraZeneca Completes Acquisition of EsoBiotec for Up to USD 1 Billion

Pulnovo Medical Raises Tens of Millions in New Financing Round
CompanyDeals

Pulnovo Medical Raises Tens of Millions in New Financing Round

PHASE Scientific Completes Series A Financing to Advance Urine-Based Diagnostics
CompanyDeals

PHASE Scientific Completes Series A Financing to Advance Urine-Based Diagnostics

China's CDE Announces 94th Batch of Reference Preparations for Generic Evaluation
Policy / Regulatory

China’s CDE Announces 94th Batch of Reference Preparations for Generic Evaluation